Kos seeks FDA OK for Niaspan caplets (Pharmaceutical Business Review) |

« FDA Approvals - Investigational Drug Paliperidone ER Significantly Delayed Symptom Recurrence In Clinical | Main | FDA Approves New Biologic Treatment for Wet Age-Related Macular Degeneration »

Kos seeks FDA OK for Niaspan caplets (Pharmaceutical Business Review)

Kos seeks FDA OK for Niaspan caplets (Pharmaceutical Business Review)
Kos Pharmaceuticals has submitted a supplemental new drug application to the FDA for a complete dosage range of Niaspan caplet formulation products.

Additional information in: FDA Approvals

FDA News Search

Get Legal Help

Breaking FDA Recalls

Breaking FDA Approvals

Health Tip

It’s a little known fact that coffee benefits your health in a variety of important ways .

Food & Drug Categories

FDA News Archive

Subscribe to this site's RSS feed
FDA Resources

FDA News Site Map
FDA Online Resources
FDA Related Resources

©2006 FDA-News.com. All rights reserved.

website free tracking